LONA
LONA clinical trials: LeonaBio, Inc.
Every trial on ClinicalTrials.gov where LeonaBio, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 9
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
LONA on the catalyst calendar · LONA registry changes
- Primary completion Apr 2027Sponsor estimatePhase 3NCT05696626Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or...LeonaBio · Metastatic Breast CancerRecruitingLONALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 15, 2024ActualPhase 2/Phase 3NCT04488419ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseLeonaBio · Alzheimer DiseaseCompletedLONALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 23, 2024ActualPhase 2/Phase 3NCT04886063Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseLeonaBio · Alzheimer DiseaseTerminatedLONALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 19, 2023ActualPhase 2NCT04831281ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)LeonaBio · Parkinson Disease DementiaTerminatedLONALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 25, 2024ActualPhase 1NCT06432647A SAD and MAD Study of the Safety, Tolerability, and Pharmacokinetics of ATH-1105LeonaBio · Healthy VolunteersCompletedLONALeadFTRECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 9, 2022ActualPhase 1NCT05169671Safety, Tolerability, and Pharmacokinetics Study of ATH-1020LeonaBio · Healthy VolunteersCompletedLONALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 20, 2022ActualPhase 2NCT04491006A Study of ATH-1017 in Mild to Moderate Alzheimer's DiseaseLeonaBio · Alzheimer DiseaseCompletedLONALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 18, 2022ActualPhase 1NCT05511558A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)LeonaBio · Healthy VolunteersCompletedLONALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 5, 2019ActualPhase 1NCT03298672Safety, Tolerability, and Pharmacokinetics Study of NDX-1017LeonaBio · Alzheimer DiseaseCompletedLONALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner